[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
INDICES> Racecadotril (Acetorphan) (2)
- From: "Randy Trinkle" <rtrinkle@gumby.citytel.net>
- Date: Mon, 30 Oct 2000 16:29:27 -0500 (EST)
INDICES> Racecadotril (Acetorphan) (2)
--------------------------------------
See contact information for the principal investigator at the bottom
of the abstract:
The New England Journal of Medicine
-- August 17, 2000 -- Vol. 343, No. 7
Racecadotril in the Treatment of Acute Watery Diarrhea in Children
Eduardo Salazar-Lindo, Javier Santisteban-Ponce, Elsa Chea-Woo,
Manuel Gutierrez
Background. Racecadotril (acetorphan), an enkephalinase inhibitor
with antisecretory and antidiarrheal actions, is an effective and safe
treatment for acute diarrhea in adults and children. Whether
treatment with racecadotril and oral rehydration therapy is more
effective than treatment with oral rehydration alone in hospitalized
children with acute watery diarrhea is not known.
Methods. We treated 135 boys 3 to 35 months of age who had
watery diarrhea of five days' duration or less with racecadotril (1.5
mg per kilogram of body weight orally every eight hours) or
placebo, in addition to oral rehydration solution. The primary end
point was the 48-hour stool output (measured in grams); the total
stool output, duration of diarrhea, and total intake of oral
rehydration solution were also measured.
Results. The mean (±SE) 48-hour stool output was 92±12 g per
kilogram in the racecadotril group and 170±15 g per kilogram in the
placebo group (P<0.001), a 46 percent reduction with racecadotril.
The results were similar among the 73 boys with rotavirus
infections. The total stool output was 157±27 g per kilogram in the
racecadotril group and 331±39 g per kilogram in the placebo group
(P<0.001). The median duration of diarrhea was significantly less
(P<0.001) in the racecadotril group (28 hours regardless of rotavirus
status) than in the placebo group (72 and 52 hours, respectively,
for rotavirus-positive and rotavirus-negative patients). The intake of
oral rehydration solution was significantly lower in the racecadotril
group than in the placebo group (P<0.001). Racecadotril was well
tolerated; only seven patients taking racecadotril had adverse
effects, which were all mild and transient.
Conclusions. In young boys with acute watery diarrhea,
racecadotril is an effective and safe treatment.
>From the Department of Pediatrics, Hospital Nacional Cayetano
Heredia, Lima, Peru. Address reprint requests to Dr. Salazar-Lindo
at Av. Benavides 264, Of. 501, Miraflores, Lima 18, Peru, or at
edsal@upch.edu.pe .
*******************************
Randy Trinkle, BScPharm BA
Clinical Pharmacist
Prince Rupert Regional Hospital
Prince Rupert, BC
Health Science Links:
http://www.rupert.net/~rtrinkle
[so what? Is the amount of stools a clinically relevant outcome? Did they measure dehydration status?
What is the cost? What were the sideeffects? Do we now give this as an additional drug to ORS? WB]
--
Send mail for the `INDICES' conference to `indices@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-indices@usa.healthnet.org'.
|